G250-antibody radiolabeled

radiolabeled G250-antibody · Heidelberg Pharma AG

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for G250-antibody radiolabeled, covering 2014-04-14 to 2014-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody [Phase 3]